Cancer Inhibitors from Chinese Natural Medicines

Front Cover
CRC Press, Nov 25, 2016 - Medical - 731 pages

Nature is an attractive source of therapeutic and preventive compounds, and with such chemical diversity found in millions of species of plants, over 60% of currently used anticancer agents are derived from natural sources. Cancer Inhibitors from Chinese Natural Medicines summarizes new advancements in the experimental and clinical research of a selection of promising cancer inhibitors. It focuses on the latest scientific investigations of 238 Chinese herbs and discusses important aspects, including the types of inhibitors in the herbs, level of potency, mechanisms, and the advances in modification and formulation. Formulations from nano-particulates and immunotoxins in cancer inhibitors are also included in this comprehensive resource.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Preface
xlvii
Author
xlix
List of Herbs
li
Anticancer Activities of Exogenous Pathogenic FactorEliminating Herbs
1
Anticancer Potentials of Antipyretic Herbs
17
Anticancer Potentials of Antirheumatics Plant Herbs
193
Anticancer Potentials of Internal ColdDispelling Herbs
277
Anticancer Potentials of Vital EnergyRegulating Herbs
291
Anticancer Potentials of Tonic Herbs
481
Anticancer Potentials of Purgative and Diuretic Herbs
571
Anticancer Potentials of Hard LumpResolving and SwellingReducing Herbs
603
Anticancer Agents from Antispasmodic Chinese Herbs
659
Anticancer Potentials of Anthelmintic Herbs
671
Anticancer Potentials of Other Herbs
685
Index of Latin Names for Chinese Herbs
717
Index of Chinese Names for Chinese Herbs
725

Anticancer Potentials of BloodActivating and StasisResolving Herbs
309
Anticancer Potentials of Hemostatic Herbs
401
Anticancer Potentials of Expectorant Antitussive and Antiasthmatic Herbs
441

Other editions - View all

Common terms and phrases

About the author (2016)

Jun-Ping Xu earned a PhD in pharmaceutical sciences and medicinal chemistry at the Tokyo University of Pharmacy and Life Sciences in Japan in 1988. He has worked at the Shanghai Institute of Pharmaceutical Industry and the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Dr. Xu currently works at the Cancer Research Institute and School of Molecular Sciences at Arizona State University, USA, as a research professor.

Bibliographic information